Boardroom Alpha
Boardroom Alpha
HQY · Additional Proxy Materials (DEFA14A) · Filed May 13, 2026

Healthequity Inc — Additional Proxy Materials (DEFA14A)

Form
DEFA14A
Filed
May 13, 2026
Ticker
HQY
Accession
0001428336-26-000023
Boardroom Alpha · Filing insights

HealthEquity, Inc.: Consult the filing for more details.

About Healthequity Inc
Market cap
$7.7B
1Y TSR
+14.3%
3Y TSR
+15.1%
Board grade
B
Sector
Healthcare
CEO
Scott Cutler
Last annual meeting: Jun 25, 2026 · View full Healthequity Inc profile →
DEFA 14A

 
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
 
Washington, D.C. 20549
 
SCHEDULE 14A
 
Proxy Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934 (Amendment No.       )
 
Filed by the Registrant  x
 
Filed by a Party other than the Registrant  ¨
 
Check the appropriate box:
 
¨Preliminary Proxy Statement
 
¨Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
 
¨Definitive Proxy Statement
 
xDefinitive Additional Materials
 
¨Soliciting Material under §240.14a-12
 
HealthEquity, Inc.
(Name of Registrant as Specified In Its Charter)
 
 
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
  
Payment of Filing Fee (Check the appropriate box):
 
xNo fee required.
 
¨Fee paid previously with preliminary materials.
 
¨Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a6(i)(1) and 0-11
 
 
 
 



Your Vote Counts! Smartphone users Point your camera here and vote without entering a control number For complete information and to vote, visit www.ProxyVote.com Control # V95522-P49787 *Please check the meeting materials for any special requirements for meeting attendance. BROADRIDGE CORPORATE ISSUER SOLUTIONS C/O HEALTHEQUITY, INC. P.O. BOX 1342 BRENTWOOD, NY 11717 HEALTHEQUITY, INC. 2026 Annual Meeting Vote by June 24, 2026 11:59 PM ET You invested in HEALTHEQUITY, INC. and it’s time to vote! You have the right to vote on proposals being presented at the Annual Meeting. This is an important notice regarding the availability of proxy materials for the stockholder meeting to be held on June 25, 2026. Get informed before you vote View the Notice and Proxy Statement, Annual Report and Form 10-K online OR you can receive a free paper or email copy of the material(s) by requesting prior to June 11, 2026. If you would like to request a copy of the material(s) for this and/or future stockholder meetings, you may (1) visit www.ProxyVote.com, (2) call 1-800-579-1639 or (3) send an email to sendmaterial@proxyvote.com. If sending an email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy. Vote Virtually at the Meeting* June 25, 2026 10:00 a.m., Mountain Daylight Time Virtually at: www.virtualshareholdermeeting.com/HQY2026


 
Vote at www.ProxyVote.com Prefer to receive an email instead? While voting on www.ProxyVote.com, be sure to click “Delivery Settings”. Voting Items Board Recommends V95523-P49787 THIS IS NOT A VOTABLE BALLOT This is an overview of the proposals being presented at the upcoming stockholder meeting. Please follow the instructions on the reverse side to vote these important matters. 1. Election of ten directors to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Nominees: 1a. Robert Selander For 1b. Scott Cutler For 1c. Stephen Neeleman, M.D. For 1d. Adrian Dillon For 1e. Evelyn Dilsaver For 1f. William Gassen For 1g. Debra McCowan For 1h. Rajesh Natarajan For 1i. Stuart Parker For 1j. Gayle Wellborn For 2. To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for our fiscal year ending January 31, 2027. For 3. To approve, on a non-binding, advisory basis, the fiscal 2026 compensation paid to our named executive officers. For 4. Approval of the HealthEquity, Inc. 2026 Employee Stock Purchase Plan. For 5. To approve the Amended and Restated HealthEquity, Inc. 2024 Equity Incentive Plan. For NOTE: Such other business as may properly come before the meeting or any adjournment thereof.


 

From this filing to the vote

Forecast every director vote the day the proxy files.

Meeting Forecast scores each director up for re-election + every contested situation, rebuilt daily across 6,000+ U.S. public companies. The same model that called the LULU contested proxy lives on every meeting you see here.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Healthequity Inc (HQY)

Reference

Frequently asked questions

When did Healthequity Inc file this DEFA14A?
Healthequity Inc (HQY) filed this Additional Proxy Materials (DEFA14A) with the SEC on May 13, 2026. The accession number assigned by EDGAR is 0001428336-26-000023.
What does a DEFA14A disclose?
DEFA14A is additional definitive proxy soliciting material filed in connection with a shareholder meeting — supplemental letters, slides, or amendments issued after the main proxy statement.
What is the key takeaway from this filing?
HealthEquity, Inc.: Consult the filing for more details. This is Boardroom Alpha's one-line summary of the additional proxy materials; see the full filing text above for the formal disclosure.
Where can I find Healthequity Inc's prior proxy statements on EDGAR?
The SEC EDGAR browser lists every DEFA14A Healthequity Inc has filed under CIK 1428336, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer